Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 20, 2000International Journal of CancerOpen Access

High levels of TIMP-2 correlate with adverse prognosis in breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ARAlbert G. RemacleUniversity of East AngliaKMKevin R. McCarthyUniversity of PittsburghANAgnès NoëlGoethe University Frankfurt

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Remacle et al. (2000) studied this question.

synapsesocial.com/papers/6a8933f2ab4588dbccfb8ab8https://doi.org/10.1002/(sici)1097-0215(20000320)89:2<118::aid-ijc3>3.0.co;2-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer1999 · 148 citations
  2. 2Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis.1993 · 219 citations
  3. 3Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer1998 · 191 citations
  4. 4In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.1998 · 401 citations